AstraZeneca’s combination of AstraZeneca’s blockbuster cancer drug Tagrisso with chemotherapy to treat a type of lung cancer has been approved by the US Food and Drug Administration.
The US FDA has approved AstraZeneca’s Tagrisso and chemotherapy combination
POPULAR POSTS
China evacuates entire city due to record rain and winds
April 26, 2024
More than 100 grinds run aground in Western Australia
April 26, 2024
LIVE STREAM